Structures by: Salem M.
Total: 9
1-(1,3-Benzothiazol-2-yl)propan-2-ol
C10H11NOS
Acta Crystallographica Section E (2005) 61, 9 o3027-o3029
a=15.7702(11)Å b=7.8856(4)Å c=15.8703(11)Å
α=90° β=101.135(5)° γ=90°
C18H17NO4S
C18H17NO4S
Acta Crystallographica Section E (2001) 57, 4 o362-o363
a=13.6308(8)Å b=15.1336(9)Å c=16.1540(10)Å
α=90.000(4)° β=151.086(3)° γ=90.000(10)°
Methyl (2-benzylidene-3-oxo-1,4-benzothiazin-4-yl)acetate
C18H15NO3S
Acta Crystallographica Section E (2001) 57, 6 o498-o499
a=19.0388(6)Å b=9.6511(3)Å c=20.9817(6)Å
α=90.0° β=155.4920(10)° γ=90.0°
Ethyl 3-methyl-1-oxo-4H-1,4-benzothiazine-2-carboxylate
C12H13NO3S
Acta Crystallographica Section E (2005) 61, 8 o2716-o2717
a=12.9935(13)Å b=33.042(4)Å c=11.1555(13)Å
α=90° β=90° γ=90°
Phényltriazole.
C9H10N4
Acta Crystallographica Section E (2008) 64, 4 o684
a=8.5110(5)Å b=11.2490(8)Å c=10.1048(7)Å
α=90.00° β=101.866(4)° γ=90.00°
Dimethyl 3-acetyl-3-(1,3-benzothiazol-2-yl)pentanedioate
C16H17NO5S
Acta Crystallographica Section E (2008) 64, 12 o2290
a=14.4075(3)Å b=8.8089(2)Å c=13.8968(3)Å
α=90.00° β=118.0110(10)° γ=90.00°
Ethyl 6-amino-5-cyano-4-isopropyl-2-methyl-4<i>H</i>-pyran-3-carboxylate
C13H18N2O3
Acta Crystallographica Section E (2009) 65, 1 o39
a=8.08560(10)Å b=9.3193(2)Å c=10.4563(2)Å
α=65.6520(10)° β=69.6790(10)° γ=76.1050(10)°
3-(Benzothiazol-2-yl)-3-(prop-2-ynyl)hex-5-yn-2-one
C16H13NOS
Acta Crystallographica Section E (2010) 66, 4 o857
a=7.79130(10)Å b=30.2051(6)Å c=12.4437(2)Å
α=90.00° β=106.1610(10)° γ=90.00°
Bis[bis(salicylato)(1,10-phenanthroline) (dimethylformamide)cadmium(II)] dimethylformamide, (C~58~H~50~Cd~2~N~6~O~14~), C~3~H~7~NO
2(C29H25CdN3O7),C3H7NO
Zeitschrift für Kristallographie - New Crystal Structures (2009) 224, 4 673
a=9.8570(17)Å b=11.0050(16)Å c=14.9534(24)Å
α=77.368(15)° β=79.268(15)° γ=69.065(13)°